Literature DB >> 9546396

The unusual active site of Gal6/bleomycin hydrolase can act as a carboxypeptidase, aminopeptidase, and peptide ligase.

W Zheng1, S A Johnston, L Joshua-Tor.   

Abstract

The Gal6 protease is in a class of cysteine peptidases identified by their ability to inactivate the anti-cancer drug bleomycin. The protein forms a barrel structure with the active sites embedded in a channel as in the proteasome. In Gal6 the C termini lie in the active site clefts. We show that Gal6 acts as a carboxypeptidase on its C terminus to convert itself to an aminopeptidase and peptide ligase. The substrate specificity of the peptidase activity is determined by the position of the C terminus of Gal6 rather than the sequence of the substrate. We propose a model to explain these diverse activities and Gal6's singular ability to inactivate bleomycin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9546396     DOI: 10.1016/s0092-8674(00)81150-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  10 in total

1.  Purification and characterization of a cobalt-activated carboxypeptidase from the hyperthermophilic archaeon Pyrococcus furiosus.

Authors:  T C Cheng; V Ramakrishnan; S I Chan
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  A papain-like enzyme at work: native and acyl-enzyme intermediate structures in phytochelatin synthesis.

Authors:  Denis Vivares; Pascal Arnoux; David Pignol
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-09       Impact factor: 11.205

3.  Cysteine proteases bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant huntingtin.

Authors:  Tamara Ratovitski; Ekaterine Chighladze; Elaine Waldron; Ricky R Hirschhorn; Christopher A Ross
Journal:  J Biol Chem       Date:  2011-02-10       Impact factor: 5.157

4.  Mutagenesis and crystallographic studies of the catalytic residues of the papain family protease bleomycin hydrolase: new insights into active-site structure.

Authors:  Paul A O'Farrell; Leemor Joshua-Tor
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

5.  Design and Synthesis of Activity-Based Probes and Inhibitors for Bleomycin Hydrolase.

Authors:  Wouter A van der Linden; Ehud Segal; Matthew A Child; Anna Byzia; Marcin Drąg; Matthew Bogyo
Journal:  Chem Biol       Date:  2015-08-06

Review 6.  Protective mechanisms against the antitumor agent bleomycin: lessons from Saccharomyces cerevisiae.

Authors:  Dindial Ramotar; Huijie Wang
Journal:  Curr Genet       Date:  2003-04-16       Impact factor: 3.886

7.  Astrogliosis and behavioral changes in mice lacking the neutral cysteine protease bleomycin hydrolase.

Authors:  S E Montoya; E Thiels; J P Card; J S Lazo
Journal:  Neuroscience       Date:  2007-03-27       Impact factor: 3.590

8.  A Commensal Dipeptidyl Aminopeptidase with Specificity for N-Terminal Glycine Degrades Human-Produced Antimicrobial Peptides in Vitro.

Authors:  Janice H Xu; Zhenze Jiang; Angelo Solania; Sandip Chatterjee; Brian Suzuki; Christopher B Lietz; Vivian Y H Hook; Anthony J O'Donoghue; Dennis W Wolan
Journal:  ACS Chem Biol       Date:  2018-08-23       Impact factor: 5.100

9.  Identification of Nucleophilic Probes for Protease-Mediated Transpeptidation.

Authors:  Ga-Eul Eom; Seokhee Kim
Journal:  Molecules       Date:  2018-08-22       Impact factor: 4.411

10.  CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis.

Authors:  Alexander G Thompson; Elizabeth Gray; Imre Mäger; Marie-Laëtitia Thézénas; Philip D Charles; Kevin Talbot; Roman Fischer; Benedikt M Kessler; Mathew Wood; Martin R Turner
Journal:  Clin Proteomics       Date:  2020-08-17       Impact factor: 3.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.